STERIS plc Accounts Receivable, Credit Loss Expense (Reversal)
STERIS plc (STE) reported Accounts Receivable, Credit Loss Expense (Reversal) of $6.76 million for the 12-month period ending 2020-03-31, per its 8-K filed 2021-02-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2021-02-09
- STERIS plc accounts receivable, credit loss expense (reversal) for fiscal 2017 was $1.25M.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|
| 2020-03-31 | $6.76M 8-K · filed 2021-02-09 |
| 2019-03-31 | $356.00K 8-K · filed 2021-02-09 |
| 2018-03-31 | $2.18M 8-K · filed 2021-02-09 |
| 2017-03-31 | $1.25M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |